[Anti-cytokine treatment, newly developed].

Research output: Contribution to journalArticle

Abstract

Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis that causes pain, loss of function and disability, and can significantly reduce health-related quality of life. Improved understanding of the pathogenesis has led to the development of new biologic treatments that target specific cytokines. Large randomized controlled trials (RCTs) have been conducted to show the efficacy of anti-TNF and IL-6. However, despite these treatments, some patients fail to respond to these therapies. Recently other anti-ctyokine treatments had been developed and introduced. Here, we discuss about new anti-cytokine treatments for RA.

Original languageEnglish
Pages (from-to)1253-1260
Number of pages8
JournalNihon rinsho. Japanese journal of clinical medicine
Volume71
Issue number7
Publication statusPublished - 2013 Jul

Fingerprint

Cytokines
Rheumatoid Arthritis
Therapeutics
Synovitis
Interleukin-6
Randomized Controlled Trials
Quality of Life
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Anti-cytokine treatment, newly developed]. / Hanaoka, Hironari; Takeuchi, Tsutomu.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 71, No. 7, 07.2013, p. 1253-1260.

Research output: Contribution to journalArticle

@article{2bf7ded5598b4c26b9793e582f985639,
title = "[Anti-cytokine treatment, newly developed].",
abstract = "Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis that causes pain, loss of function and disability, and can significantly reduce health-related quality of life. Improved understanding of the pathogenesis has led to the development of new biologic treatments that target specific cytokines. Large randomized controlled trials (RCTs) have been conducted to show the efficacy of anti-TNF and IL-6. However, despite these treatments, some patients fail to respond to these therapies. Recently other anti-ctyokine treatments had been developed and introduced. Here, we discuss about new anti-cytokine treatments for RA.",
author = "Hironari Hanaoka and Tsutomu Takeuchi",
year = "2013",
month = "7",
language = "English",
volume = "71",
pages = "1253--1260",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "7",

}

TY - JOUR

T1 - [Anti-cytokine treatment, newly developed].

AU - Hanaoka, Hironari

AU - Takeuchi, Tsutomu

PY - 2013/7

Y1 - 2013/7

N2 - Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis that causes pain, loss of function and disability, and can significantly reduce health-related quality of life. Improved understanding of the pathogenesis has led to the development of new biologic treatments that target specific cytokines. Large randomized controlled trials (RCTs) have been conducted to show the efficacy of anti-TNF and IL-6. However, despite these treatments, some patients fail to respond to these therapies. Recently other anti-ctyokine treatments had been developed and introduced. Here, we discuss about new anti-cytokine treatments for RA.

AB - Rheumatoid arthritis (RA) is characterized by chronic inflammatory synovitis that causes pain, loss of function and disability, and can significantly reduce health-related quality of life. Improved understanding of the pathogenesis has led to the development of new biologic treatments that target specific cytokines. Large randomized controlled trials (RCTs) have been conducted to show the efficacy of anti-TNF and IL-6. However, despite these treatments, some patients fail to respond to these therapies. Recently other anti-ctyokine treatments had been developed and introduced. Here, we discuss about new anti-cytokine treatments for RA.

UR - http://www.scopus.com/inward/record.url?scp=84886488016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886488016&partnerID=8YFLogxK

M3 - Article

C2 - 23961676

AN - SCOPUS:84886488016

VL - 71

SP - 1253

EP - 1260

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 7

ER -